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After many years of essentially ignoring or con-
sidering Modic changes (MC) as seen on MRI 
scans as incidental findings, a new era began 
with the publication of Kjær et al. 10 years ago, 
who were the first research group in the world 
to demonstrate a clear correlation between MC 
and the 1-year prevalence of back pain [1]. This 
important discovery ‘upset’ the prevailing con-
sensus among back specialists that back pain 
was predominantly a biopsychosocial phenom-
enon with an emphasis on the psychosocial 
dimension [2]. Since Kjær et al.’s publication, 
the biological dimension of back pain has 
become a hot topic among back pain research-
ers throughout the world. Currently, new pub-
lications dealing with Modic-related topics are 
published almost weekly in scientific journals.
We will introduce the reader to the concept 
of MC and present the current status of our 
knowledge from the very latest scientific litera-
ture including the presence of Propionibacter­
ium acnes inside the disc. Many of the bricks 
involved in this puzzle are beginning to form a 
biologically sound ‘picture’.
Definitions, pathoanatomy/genesis, 
symptoms & treatment
In the literature [3,4], three types of MC 
are defined; MC type 1, type 2 and type 3. 
Type 1 is characterized by high signal inten-
sity on T2-weighted images (Figure 1) and 
low signal intensity on T1-weighted images. 
The extent of each MC can vary from a nar-
row fringe that simply involves the end plate 
of the vertebra to spreading into large parts 
of the adjacent vertebra. MC type 2 is char-
acterized by high signal intensity on both T1- 
and T2-weighted images. MC type 1 con-
tains vascular tissue and active inflammatory 
agents; type 2 contains granulation tissue 
infiltrated by significant amounts of fat cells. 
This has been demonstrated in biopsy stud-
ies. MC Type 3 are rare and do not appear 
to have any clinical relevance. They repre-
sent subchondral bony sclerosis with low 
T1 and T2 signal intensity. In patients with 
prolonged back pain, the prevalence of MC 
is 40%. In individuals with MC, more than 
90% will have back pain within 1 year. MC 
often causes localized pain 24/7 and noctur-
nal pain is the rule rather than the excep-
tion [5]. A direct correlation between the size 
of the MCs as seen over time and pain inten-
sity variations has been demonstrated [6]. MC 
type 1 are an important prognostic marker 
of a poor prognosis regarding relentless pain 
and reduced daily function [6]. We refer to 
references [4] and [7] for additional detail.
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The most common cause of MC may well be that 
the ordinary disc degenerative processes involving 
damage and microfractures to the vertebral end plates 
(Figure 2; nr. 0-1-2). In some patients, the degenera-
tive process results in the development of edema and 
inflammation of the adjacent vertebrae. Several fac-
tors may be involved: end plate damage following 
disc herniation, ingrowth of capillaries and inflam-
matory agents related to the end plate structure may 
be important ingredients in the development of pain 
and MC in the involved spinal segment [9]. As the 
bony end plates normally have a rich supply of small 
free nerve endings, degenerative developments and 
inflammation likely trigger localized inflammatory 
pain [9].
Following disc herniations or annular tears, bacte-
ria may enter the disc and initiate a discitis (Figure 2: 
nr. 0-3-4-5) [4]. Low or high virulent infections may 
take place depending upon the bacterial species or sub-
type [10]. Anaerobic P. acnes bacteria are often present in 
the herniated mass following an acute disc herniation [4].
The degenerative and the infectious pathways 
may work concurrently and together accelerate the 
destruction of the spinal segment structures [9,11].
In most cases, treatment is similar to that recom-
mended for other cases of disc degeneration/spondy-
losis that are not spontaneously improving. In most 
cases, no relief is seen following back exercises or 
general training [4]. If there is a suspicion of a disc 
infection, prolonged antibiotic therapy may be an 
effective treatment. In 2013, a randomized clini-
cal trial (RCT) with 1-year follow-up RCT investi-
gated the efficacy of amoxicillin/clavulanic acid for 
a 3-month period in patients with disc herniations 
and MC type 1 as seen on MRI [12]. In more than 
50–60% of these patients clinically relevant and 
statistically significant improvements were seen at 
the end of treatment with further improvement in 
the actively treated group up to 1-year follow-up. 
Another smaller RCT with no follow-up period also 
demonstrated a positive clinical effect of antibiotic 
treatment in patients with MC type 1 [13]. Several 
large RCTs are underway or in the planning stages 
in Norway, Australia and the UK.
The infectious pathway: the scientific case
It has been acknowledged for many years that disc 
degeneration – typically initiated by trauma or local 
mechanical forces – involved the vertebral end plates 
during the progressive destructive phase, in some 
patients. The resulting end plate damage is associated 
with the MRI finding, MC [9–11].
In 2008, a Danish research group proposed the 
theory that in addition to the degenerative/mechani-
cal pathway toward developing MC, an alternative 
infectious pathway likely took place concurrently [4]. 
The infectious pathway takes place as a result of a 
series of occurrences in and around the disc and end 
plates as is the case for the degenerative/mechanical 
pathway. The latest research in this field appears to 
confirm the existence of an infectious pathway:
•	 Low virulent bacteria enter the disc following 
a herniation or small trauma related annular 
tears [11,14]. This process may well be facilitated 
by the tearing of end plate fragments often seen 
in biopsies of herniated material that render 
the end plate damaged, which also delays her-
niated disc material resorption and results in 
neovascularization [15–18];
•	 The bacteria are randomly transported through 
the circulatory system to the discs or may enter 
from contamination in spinal-related surgical 
procedures [4,11,18];
Figure 1. An MRI T2-weighted image. Typical Modic 
changes type 1 (high signal intensity) in a lumbar 
segment. 
Reproduced with permission from [4].
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•	 When the skin barrier is broken, there is a risk 
of bacterial spreading from the folds of the skin 
and sebaceous glands to spine despite sterilization 
procedures [19]. In some cases, the invading bacte-
ria may have a nonskin origination, for example, 
from the oral cavity, as shown by Rollason et al. in 
a phylogenetic study [20];
•	 The most commonly found bacteria in the disc 
and herniated discal tissue are different subtypes 
of P. acnes [20–22];
•	 Bacteria with sufficiently virulent characteristics 
are able to colonize intradiscally [10];
•	 This is followed by inflammation and accel-
erated degeneration that in turn leads to end 
plate damage and MC changes as seen on MRI 
scans [10,23,24];
•	 Disc-related inflammation will lead to back pain 
and the injection of anti-inflammatory agents has 
demonstrated short-term pain reduction in several 
studies [23,25];
•	 A long-term antibiotic regimen results in a 50% 
reduction of pain in 50% of patients with low 
back pain following a disc herniation and Modic 
changes type 1 [12,13].
Conclusion & future perspective
As the infectious pathway is shown to exist as an alter-
native to the degenerative/mechanical pathway, it is 
relevant to ask how we can differentiate the diagnoses 
‘low virulent bacterial discitis/MC’ from ‘mechani-
cal disc degeneration/MC?’ In which cases is antibi-
otic treatment relevant to consider? Which antibiotic 
regimes are most effective and provide the patients 
and the environment with the highest degree of pro-
tection? Are there other treatment alternatives? Can 
one imagine preventative steps which may prevent a 
bacterial infection through contamination?
There are currently no conclusive answers to these 
questions.
We must acknowledge that differing analyti-
cal methods used to identify which bacteria are 
found in discs are by no means effective. When the 
spread of findings ranges from 3 to 53% regarding 
the presence of bacteria in discal tissue [11], this is 
likely due to poor and difficult analytical meth-
ods. More readily available and reliable analytical 
methods are required. Perhaps it may be possible to 
develop blood tests that are sensitive for intradiscal 
bacterial infection?
The MRI-based diagnostics are not completed yet. 
End plate damage has not been standardized [4,26] and 
the interpretation of MC types 1 and 2 are often based 
upon the radiologists’ subjective evaluation.
It seems appropriate to treat patients with MC 
type 1. It is, therefore, imperative to continue research-
ing the utilization of antibiotic treatment for this con-
dition. Which treatment regimen is most effective? Is 
perioperative preventative antibiotic treatment relevant 
in the prevention of low virulent discitis?
P. acnes beyond the skin may result in many differ-
ent serious opportunistic infections: in bone, implants, 
glands, lungs and vascular tissues, and there are still 
many unanswered questions before puzzle has been 
completed [27].
The current increased documentation of an infec-
tious pathway in disc disease has increased our need to 
Figure 2. The development of Modic changes. Two 
associated pathways. Mechanical pathway: (0) normal 
disc; (1) age-related disc degeneration and the 
development of spondylosis; (2) end plate damage 
with development of Modic changes type 1. Infectious 
pathway: (3) disc degeneration with the development 
of a disc herniation; (4) invasion of bacteria, causing a 
disc infection; (5) end plate damage and bacteria with 
the development of Modic changes type 1. 
Reproduced with permission from [8].
4
5
3
0
1
2
future science group10.4155/fsoa-2016-0017 Future Sci. OA (2016) FSO117
Editorial    Manniche & Jordan
address the related questions not least due to the fact 
that appropriate treatment forms for this condition 
already seems to be visible in the horizon.
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